1. AB0334 Very high titer of anti-citrullinated protein antibodies is associated with the achievement of clinical remission by abatacept in biologic-naïve patients with rheumatoid arthritis (the abroad study). (23rd January 2014) Authors: Fujii, T.; Sekiguchi, M.; Matsui, K.; Kitano, M.; Hashimoto, M.; Ohmura, K.; Yamamoto, A.; Nakahara, H.; Maeda, K.; Yokota, A.; Miki, K.; Shimmyo, N.; Kuroiwa, T.; Murakami, K.; Ozaki, Y.; Higami, K.; Yoshii, I.; Nozaki, Y.; Ikawa, T.; Morita, S. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0472 Predicting Factors Associated with Sustained Clinical Remission by Abatacept are Different Between in Younger and Elderly Patients with Biologic-Naïve Rheumatoid Arthritis (Abroad Study). (9th June 2015) Authors: Sekiguchi, M.; Fujii, T.; Kitano, M.; Matsui, K.; Hashimoto, H.; Yokota, A.; Miki, K.; Yamamoto, A.; Fujimoto, T.; Hidaka, T.; Shimmyo, N.; Maeda, K.; Kuroiwa, T.; Yoshii, I.; Murakami, K.; Ohmura, K.; Morita, S.; Kawahito, Y.; Nishimoto, N.; Mimori, T. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1054 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0206 Abatacept (CTLA4-IG) suppresses T cell activation and reduces TH17 cells as well as plasma IL-6 in patients with rheumatoid arthritis. (23rd January 2014) Authors: Matsutani, T.; Li, Y.; Murakami, M.; Lee, H.-M.; Aoki, C.; Sekiguchi, M.; Matsui, K.; Kitano, M.; Namiki, M.; Ohmura, K.; Murakami, K.; Fujii, T.; Kuroiwa, T.; Shimaoka, Y.; Nakahara, H.; Maeda, K.; Irimajiri, S.; Funauchi, M.; Imura, Y.; Ikawa, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1805P wave vector electrography calculated from routine 12-lead ECG predicts recurrence of atrial fibrillation after pulmonary vein isolation. (20th June 2017) Authors: Imai, Y.; Watanabe, H.; Kabutoya, T.; Komori, T.; Watanabe, T.; Yokota, A.; Hachiya, H.; Kario, K. Journal: Europace Issue: Volume 19(2017)Supplement 3 Page Start: iii400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0101 Abatacept Treatment Suppresses T Cell Activation in Anti-Cyclic Citrullinated Peptide Antibody (ACPA) Positive RA Patients but not in Acpa Negative RA Patients. (23rd January 2014) Authors: Matsutani, T.; Murakami, M.; Sekiguchi, M.; Matsui, K.; Kitano, M.; Namiki, M.; Ohmura, K.; Imura, Y.; Fujii, T.; Kuroiwa, T.; Nakahara, H.; Hika, S.; Maeda, K.; Nozaki, Y.; Funauchi, M.; Murakami, K.; Ikawa, T.; Irimajiri, S.; Nampei, A.; Azuma, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0121 Changes in Cytokine Profiles in Rheumatoid Arthritis Patients During Abatacept Treatment. (23rd January 2014) Authors: Murakami, M.; Matsutani, T.; Sekiguchi, M.; Matsui, K.; Kitano, M.; Namiki, M.; Ohmura, K.; Imura, Y.; Fujii, T.; Kuroiwa, T.; Nakahara, H.; Higa, S.; Maeda, K.; Nozaki, Y.; Funauchi, M.; Murakami, K.; Ikawa, T.; Irimajiri, S.; Nampei, A.; Azuma, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗